banner add

F.D.A. Approves New Obesity Drug Tirzepatide That Will Compete With Wegovy

Zepbound, which is already sold by Eli Lilly as the diabetes treatment Mounjaro, was shown to reduce patients’ weight by as much as one-fifth in drug trials.

from NYT > Health https://ift.tt/iYc1jw8
via IFTTT

No comments

Many World Cup Fans Would Rather Skip the Hydration Breaks

It’s hot in North America in June, but fans are griping that the breaks that have been added to each half are an excuse for the networks to ...

Theme images by PLAINVIEW. Powered by Blogger.